On the relative safety of intravenous iron formulations: new answers, new questions.
Chertow
Glenn M
GM
Winkelmayer
Wolfgang C
WC
D000707:Anaphylaxis / Q000139:chemically induced* / Q000401:mortality*; D004342:Drug Hypersensitivity / Q000401:mortality*; D005290:Ferric Compounds / Q000008:administration & dosage / Q000009:adverse effects*; D006397:Hematinics / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D012189:Retrospective Studies; D012307:Risk Factors; D014481:United States / Q000453:epidemiology; D014486:United States Food and Drug Administration
D005290:Ferric Compounds; D006397:Hematinics